• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[阿霉素在播散性乳腺癌联合化疗中的应用]

[Use of adriablastin in the combination chemotherapy of disseminated breast cancer].

作者信息

Korman D B, Borisov A I, Maslova I A, Pines E V

出版信息

Vopr Onkol. 1981;27(4):44-7.

PMID:7233874
Abstract

A course of combination chemotherapy using adriamycin was given to 68 patients suffering from disseminated breast tumor. Objective and symptomatic improvement was registered in 53 cases. Out of 45 patients with bone metastases, a distinct clinical effect was observed in 41 cases. Out of 10 bed-confined cases, seven became self-dependent. Mean remission in the cases of bone metastases was 6.4 months.

摘要

对68例播散性乳腺肿瘤患者进行了使用阿霉素的联合化疗疗程。53例患者有客观和症状改善。在45例有骨转移的患者中,41例观察到明显的临床效果。在10例卧床不起的患者中,7例恢复了自理能力。骨转移患者的平均缓解期为6.4个月。

相似文献

1
[Use of adriablastin in the combination chemotherapy of disseminated breast cancer].[阿霉素在播散性乳腺癌联合化疗中的应用]
Vopr Onkol. 1981;27(4):44-7.
2
[Combination chemotherapy including anablastine in disseminated breast cancer].[含氮芥的联合化疗用于播散性乳腺癌]
Vopr Onkol. 1981;27(5):10-3.
3
[Adriablastin (doxorubicin) in the combined chemotherapy of patients with disseminated forms of breast cancer].[阿霉素(多柔比星)在播散型乳腺癌患者联合化疗中的应用]
Antibiotiki. 1984 Jun;29(6):463-8.
4
[Use of adriablastine in the combined chemotherapy of breast cancer patients with bone metastases].[阿霉素在乳腺癌骨转移患者联合化疗中的应用]
Vopr Onkol. 1980;26(8):20-4.
5
Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.吡柔比星联合5-氟尿嘧啶和环磷酰胺治疗转移性乳腺癌的II期临床与药理学研究
Clin Cancer Res. 1995 Jul;1(7):691-7.
6
[Adriamycin in the combined chemotherapy of metastatic breast cancer].[阿霉素在转移性乳腺癌联合化疗中的应用]
Vestn Akad Med Nauk SSSR. 1986(5):47-51.
7
[Prevention of cardiotoxicity of doxorubicin (Adriamycin) using cardioxane (ICRF-187, dexrazoxane) in the combination chemotherapy of disseminated breast cancer].在转移性乳腺癌联合化疗中使用心脏烷(ICRF-187,右丙亚胺)预防阿霉素(阿霉素)的心脏毒性
Vopr Onkol. 1993;39(1-3):26-32.
8
[Combination chemotherapy in metastatic breast cancer].
Harefuah. 1981 Feb 1;100(3):118-20.
9
Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.在高危原发性或转移性乳腺癌女性患者中,多柔比星和紫杉醇作为大剂量化疗及外周血祖细胞移植前诱导化疗的心脏后遗症。
Bone Marrow Transplant. 2000 May;25(10):1047-52. doi: 10.1038/sj.bmt.1702394.
10
[Regional therapy breast cancer liver metastases].[区域治疗乳腺癌肝转移]
Zentralbl Chir. 1995;120(10):786-90.